Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MOHIT KHERA and MOHIT KHERA.
MOHIT KHERA
Connection Strength
58.885
MOHIT KHERA
  1. Sexspan: a comprehensive framework for sustaining lifelong sexual health and vitality. J Sex Med. 2025 Jan 03; 22(1):4-6.
    View in: PubMed
    Score: 0.995
  2. Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression. J Sex Med. 2024 Dec 01; 21(12):1152-1158.
    View in: PubMed
    Score: 0.988
  3. Development of a new Peyronie's disease self-assessment screening app. Transl Androl Urol. 2024 Nov 30; 13(11):2617-2624.
    View in: PubMed
    Score: 0.988
  4. Erectile dysfunction as a holistic indicator of well-being: a narrative review. Sex Med Rev. 2024 Oct 04.
    View in: PubMed
    Score: 0.978
  5. Lessons learned from the Sexual Medicine Society of North America fellowship bootcamp. J Sex Med. 2024 Sep 28; 21(10):961-966.
    View in: PubMed
    Score: 0.977
  6. Advancements in ectopic reservoir placement for inflatable penile prostheses. Sex Med Rev. 2024 Sep 25; 12(4):770-781.
    View in: PubMed
    Score: 0.976
  7. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Transl Androl Urol. 2024 Sep 30; 13(9):1984-1990.
    View in: PubMed
    Score: 0.976
  8. Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2024 Sep 18.
    View in: PubMed
    Score: 0.975
  9. Lessons learned from the TRAVERSE trial. J Sex Med. 2024 Sep 03; 21(9):746-748.
    View in: PubMed
    Score: 0.972
  10. Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile. Urol Pract. 2025 Jan; 12(1):168-175.
    View in: PubMed
    Score: 0.972
  11. Sexual Medicine Society of North America (SMSNA)/American Urological Association (AUA) telemedicine and men's health white paper. J Sex Med. 2024 Mar 28; 21(4):318-332.
    View in: PubMed
    Score: 0.943
  12. First-time orgasm in a young man with lifelong anorgasmia after flibanserin use: a case report. Sex Med. 2023 Dec; 11(6):qfad066.
    View in: PubMed
    Score: 0.929
  13. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024 Sep; 27(3):507-519.
    View in: PubMed
    Score: 0.928
  14. Stem cell therapy for erectile dysfunction: a systematic review. Sex Med Rev. 2023 12 23; 12(1):87-93.
    View in: PubMed
    Score: 0.926
  15. Hyperbaric oxygen therapy as a treatment for erectile dysfunction: a meta-analysis. Sex Med Rev. 2023 12 23; 12(1):94-99.
    View in: PubMed
    Score: 0.926
  16. Will you go the distance? A satisfaction survey of telemedicine in sexual medicine. Sex Med. 2023 Dec; 11(6):qfad060.
    View in: PubMed
    Score: 0.925
  17. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. J Sex Med. 2023 11 30; 20(12):1369-1375.
    View in: PubMed
    Score: 0.922
  18. Implantable Penile Prosthesis for Erectile Dysfunction: Insurance Coverage in the United States. Urol Pract. 2023 09; 10(5):501-510.
    View in: PubMed
    Score: 0.904
  19. Quantifying the number of US men with erectile dysfunction who are potential candidates for penile prosthesis implantation. Sex Med. 2023 Apr; 11(2):qfad010.
    View in: PubMed
    Score: 0.883
  20. The Low Submuscular Reservoir Placement With Transfascial Fixation for Inflatable Penile Prostheses. J Sex Med. 2022 08; 19(8):1309-1312.
    View in: PubMed
    Score: 0.834
  21. Testosterone replacement therapy and cardiovascular disease. Int J Impot Res. 2022 Nov; 34(7):685-690.
    View in: PubMed
    Score: 0.809
  22. The Potential for Pharmacological Interventions for Low Sex Drive in Men. J Sex Med. 2022 02; 19(2):165-169.
    View in: PubMed
    Score: 0.808
  23. Ectopic low submuscular pressure regulating balloon placement with transfascial fixation for artificial urinary sphincter. Can J Urol. 2021 12; 28(6):10936-10940.
    View in: PubMed
    Score: 0.803
  24. Differential Gene Expression in Post-Finasteride Syndrome Patients. J Sex Med. 2021 09; 18(9):1479-1490.
    View in: PubMed
    Score: 0.781
  25. Testosterone's Role in COVID-19. J Sex Med. 2021 05; 18(5):843-848.
    View in: PubMed
    Score: 0.765
  26. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. J Sex Med. 2021 01; 18(1):83-98.
    View in: PubMed
    Score: 0.751
  27. Controversies in Testosterone Therapy. Sex Med Rev. 2021 01; 9(1):149-159.
    View in: PubMed
    Score: 0.750
  28. Is there still a place for malleable penile implants in the United States? Wilson's Workshop #18. Int J Impot Res. 2023 Mar; 35(2):82-89.
    View in: PubMed
    Score: 0.749
  29. Hypogonadism management and cardiovascular health. Postgrad Med. 2020 Dec; 132(sup4):35-41.
    View in: PubMed
    Score: 0.743
  30. Controversies with testosterone therapy. Can J Urol. 2020 08; 27(S3):20-23.
    View in: PubMed
    Score: 0.732
  31. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol. 2020 Jun; 9(3):1201-1209.
    View in: PubMed
    Score: 0.724
  32. Bipolar Androgen Therapy in Prostate Cancer (Update). J Sex Med. 2020 05; 17(5):831-834.
    View in: PubMed
    Score: 0.708
  33. A Critique of the AUA Guidelines on Testosterone Deficiency. J Sex Med. 2020 04; 17(4):561-564.
    View in: PubMed
    Score: 0.699
  34. Editorial Comment. J Urol. 2019 09; 202(3):610.
    View in: PubMed
    Score: 0.684
  35. An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538.
    View in: PubMed
    Score: 0.676
  36. Effect of Body Weight on Sexual Function in Men and Women. Curr Sex Health Rep. 2019 Mar; 11(1):52-59.
    View in: PubMed
    Score: 0.658
  37. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Eur Urol Focus. 2018 04; 4(3):321-323.
    View in: PubMed
    Score: 0.639
  38. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Curr Urol Rep. 2018 Jun 30; 19(8):67.
    View in: PubMed
    Score: 0.633
  39. Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788.
    View in: PubMed
    Score: 0.624
  40. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158.
    View in: PubMed
    Score: 0.616
  41. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes. Med Clin North Am. 2018 Mar; 102(2):361-372.
    View in: PubMed
    Score: 0.609
  42. Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113.
    View in: PubMed
    Score: 0.608
  43. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017 Nov; 27(6):511-515.
    View in: PubMed
    Score: 0.605
  44. Testosterone inhibits the growth of prostate cancer xenografts in nude mice. BMC Cancer. 2017 Sep 07; 17(1):635.
    View in: PubMed
    Score: 0.599
  45. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017 Feb; 6(1):28-36.
    View in: PubMed
    Score: 0.574
  46. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97.
    View in: PubMed
    Score: 0.568
  47. Testosterone therapy and prostate cancer. Transl Androl Urol. 2016 Dec; 5(6):909-920.
    View in: PubMed
    Score: 0.568
  48. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM?2015). J Sex Med. 2016 12; 13(12):1787-1804.
    View in: PubMed
    Score: 0.568
  49. Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial". J Sex Med. 2016 08; 13(8):1243-4.
    View in: PubMed
    Score: 0.555
  50. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26.
    View in: PubMed
    Score: 0.550
  51. Testosterone Therapies. Urol Clin North Am. 2016 May; 43(2):185-93.
    View in: PubMed
    Score: 0.541
  52. Male hormones and men's quality of life. Curr Opin Urol. 2016 Mar; 26(2):152-7.
    View in: PubMed
    Score: 0.539
  53. Testosterone is Protective against Cardiac Disease: Pro. J Urol. 2016 04; 195(4 Pt 1):831-2.
    View in: PubMed
    Score: 0.535
  54. Changing paradigm of men's health. Indian J Urol. 2016 Jan-Mar; 32(1):5.
    View in: PubMed
    Score: 0.533
  55. The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7.
    View in: PubMed
    Score: 0.527
  56. Testosterone Replacement in Men with Treated and Untreated Prostate Cancer. Sex Med Rev. 2013 Oct; 1(3):143-149.
    View in: PubMed
    Score: 0.525
  57. Testosterone Therapy for Female Sexual Dysfunction. Sex Med Rev. 2015 Jul; 3(3):137-144.
    View in: PubMed
    Score: 0.524
  58. Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer. Asian J Androl. 2015 Sep-Oct; 17(5):807-10.
    View in: PubMed
    Score: 0.521
  59. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6.
    View in: PubMed
    Score: 0.511
  60. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May; 12(5):1105-6.
    View in: PubMed
    Score: 0.509
  61. Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis. J Sex Med. 2015 Apr; 12(4):975-84.
    View in: PubMed
    Score: 0.503
  62. Controversies in testosterone supplementation therapy. Asian J Androl. 2015 Mar-Apr; 17(2):175-6.
    View in: PubMed
    Score: 0.503
  63. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2.
    View in: PubMed
    Score: 0.497
  64. Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul; 15(7):417.
    View in: PubMed
    Score: 0.480
  65. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33.
    View in: PubMed
    Score: 0.475
  66. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013 Sep; 66(7):729-36.
    View in: PubMed
    Score: 0.453
  67. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23.
    View in: PubMed
    Score: 0.452
  68. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J Sex Med. 2013 Aug; 10(8):1915-25.
    View in: PubMed
    Score: 0.446
  69. 12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18.
    View in: PubMed
    Score: 0.438
  70. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.436
  71. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9.
    View in: PubMed
    Score: 0.426
  72. Testosterone replacement in normal and pathologic prostate. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):347-53.
    View in: PubMed
    Score: 0.425
  73. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
    View in: PubMed
    Score: 0.409
  74. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21.
    View in: PubMed
    Score: 0.400
  75. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3.
    View in: PubMed
    Score: 0.396
  76. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13.
    View in: PubMed
    Score: 0.393
  77. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11.
    View in: PubMed
    Score: 0.392
  78. Erectile dysfunction. BMJ Clin Evid. 2011 Jun 29; 2011.
    View in: PubMed
    Score: 0.390
  79. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60.
    View in: PubMed
    Score: 0.380
  80. Revision of penile prosthesis surgery after use of penile traction therapy to increase erect penile length: case report and review of the literature. J Sex Med. 2011 Feb; 8(2):607-11.
    View in: PubMed
    Score: 0.374
  81. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep. 2010 Nov; 11(6):393-9.
    View in: PubMed
    Score: 0.372
  82. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65.
    View in: PubMed
    Score: 0.368
  83. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.329
  84. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med. 2009 Mar; 6 Suppl 3:234-8.
    View in: PubMed
    Score: 0.329
  85. Evolving approach to the varicocele. Urol Clin North Am. 2008 May; 35(2):183-9, viii.
    View in: PubMed
    Score: 0.313
  86. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.302
  87. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007 Feb; 99(2):442-6.
    View in: PubMed
    Score: 0.287
  88. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3.
    View in: PubMed
    Score: 0.274
  89. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology. 2005 Jul; 66(1):208-12.
    View in: PubMed
    Score: 0.257
  90. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004 Dec; 45(7):987-93.
    View in: PubMed
    Score: 0.247
  91. Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures. J Urol. 2004 Aug; 172(2):574-5.
    View in: PubMed
    Score: 0.241
  92. Penile constriction devices: a randomized survey study to compare preferences between two medical-grade devices. J Sex Med. 2025 Jan 03; 22(1):43-50.
    View in: PubMed
    Score: 0.062
  93. Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. Andrology. 2024 Sep 10.
    View in: PubMed
    Score: 0.061
  94. Can semen analysis be utilized as a screening tool for overall health in young men? Int J Impot Res. 2024 Jun 29.
    View in: PubMed
    Score: 0.060
  95. Changes in post-transplant serum testosterone levels in men undergoing lung transplantation: a pilot study using the TriNetX Research Network. Int J Impot Res. 2024 Jun 05.
    View in: PubMed
    Score: 0.060
  96. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024 May 28; 21(6):573-578.
    View in: PubMed
    Score: 0.060
  97. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):569-580.
    View in: PubMed
    Score: 0.058
  98. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
    View in: PubMed
    Score: 0.058
  99. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13; 389(2):107-117.
    View in: PubMed
    Score: 0.056
  100. Increasing Role of the Advanced Practice Provider in Men's Health Clinics: An Analysis of Medicare and Commercial Claims in the United States. Urol Pract. 2023 07; 10(4):320-325.
    View in: PubMed
    Score: 0.055
  101. Oral testosterone therapy: past, present, and future. Sex Med Rev. 2023 04 03; 11(2):124-138.
    View in: PubMed
    Score: 0.055
  102. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther. 2022; 3(1):217-223.
    View in: PubMed
    Score: 0.054
  103. Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 08; 18(4):528.e1-528.e6.
    View in: PubMed
    Score: 0.052
  104. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015. Cancer Epidemiol. 2022 08; 79:102172.
    View in: PubMed
    Score: 0.052
  105. Long-Term Survival Rates of Inflatable Penile Prostheses: Systematic Review and Meta-Analysis. Urology. 2022 08; 166:6-10.
    View in: PubMed
    Score: 0.051
  106. A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism. Andrology. 2022 05; 10(4):669-676.
    View in: PubMed
    Score: 0.051
  107. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022; 33(1):65-76.
    View in: PubMed
    Score: 0.050
  108. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50.
    View in: PubMed
    Score: 0.050
  109. Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100?mg IM weekly or 200?mg IM biweekly. Int J Impot Res. 2022 Sep; 34(6):558-563.
    View in: PubMed
    Score: 0.049
  110. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):630-637.
    View in: PubMed
    Score: 0.049
  111. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer. Cancer Causes Control. 2021 Sep; 32(9):965-976.
    View in: PubMed
    Score: 0.048
  112. Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A. Can Urol Assoc J. 2021 May; 15(5):E234-E243.
    View in: PubMed
    Score: 0.048
  113. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men. Cancer Prev Res (Phila). 2021 07; 14(7):719-728.
    View in: PubMed
    Score: 0.048
  114. The Emerging Critical Role of Telemedicine in the Urology Clinic: A Practical Guide. Sex Med Rev. 2021 04; 9(2):289-295.
    View in: PubMed
    Score: 0.048
  115. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature. Sex Med Rev. 2021 07; 9(3):393-405.
    View in: PubMed
    Score: 0.047
  116. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
    View in: PubMed
    Score: 0.046
  117. Response to Commentary on Contemporary Considerations in a Man With Low Sex Drive. J Sex Med. 2020 11; 17(11):2311.
    View in: PubMed
    Score: 0.046
  118. Novel Treatments of Erectile Dysfunction: Review of the Current Literature. Sex Med Rev. 2021 01; 9(1):123-132.
    View in: PubMed
    Score: 0.046
  119. Contemporary Considerations in the Pathophysiology of Low Sex Drive in Men. J Sex Med. 2020 06; 17(6):1049-1052.
    View in: PubMed
    Score: 0.044
  120. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 12; 91(6):885-891.
    View in: PubMed
    Score: 0.043
  121. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38.
    View in: PubMed
    Score: 0.042
  122. Erectile Dysfunction: AUA Guideline. J Urol. 2018 09; 200(3):633-641.
    View in: PubMed
    Score: 0.039
  123. Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54.
    View in: PubMed
    Score: 0.039
  124. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10.
    View in: PubMed
    Score: 0.039
  125. Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study. Transl Androl Urol. 2017 Dec; 6(6):1167-1174.
    View in: PubMed
    Score: 0.038
  126. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov; 93(1105):679-685.
    View in: PubMed
    Score: 0.037
  127. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95.
    View in: PubMed
    Score: 0.037
  128. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296.
    View in: PubMed
    Score: 0.036
  129. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315.
    View in: PubMed
    Score: 0.036
  130. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. J Sex Med. 2016 08; 13(8):1183-98.
    View in: PubMed
    Score: 0.035
  131. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr; 13(4):465-88.
    View in: PubMed
    Score: 0.034
  132. Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4.
    View in: PubMed
    Score: 0.033
  133. The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33.
    View in: PubMed
    Score: 0.032
  134. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015 Sep; 3(3):165-73.
    View in: PubMed
    Score: 0.032
  135. Peyronie's Disease: AUA Guideline. J Urol. 2015 Sep; 194(3):745-53.
    View in: PubMed
    Score: 0.032
  136. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med. 2015 Jun; 12(6):1375-80.
    View in: PubMed
    Score: 0.032
  137. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51.
    View in: PubMed
    Score: 0.031
  138. Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51.
    View in: PubMed
    Score: 0.031
  139. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71.
    View in: PubMed
    Score: 0.030
  140. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.030
  141. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45.
    View in: PubMed
    Score: 0.030
  142. North American consensus document on infection of penile prostheses. Urology. 2013 Oct; 82(4):937-42.
    View in: PubMed
    Score: 0.028
  143. Current opinions on alternative reservoir placement for inflatable penile prosthesis among members of the Sexual Medicine Society of North America. J Sex Med. 2013 Aug; 10(8):2115-20.
    View in: PubMed
    Score: 0.028
  144. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29.
    View in: PubMed
    Score: 0.027
  145. The treatment of hypogonadism in?men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24.
    View in: PubMed
    Score: 0.027
  146. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30.
    View in: PubMed
    Score: 0.026
  147. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98.
    View in: PubMed
    Score: 0.026
  148. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(?)) insertion. J Sex Med. 2012 Feb; 9(2):594-601.
    View in: PubMed
    Score: 0.025
  149. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011 Nov 01; 11:18.
    View in: PubMed
    Score: 0.025
  150. Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med. 2011 Jul; 8(7):1996-2001.
    View in: PubMed
    Score: 0.024
  151. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27.
    View in: PubMed
    Score: 0.024
  152. Reply by authors. J Urol. 2010 Jun; 183(6):2315.
    View in: PubMed
    Score: 0.022
  153. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010 Jun; 183(6):2309-15.
    View in: PubMed
    Score: 0.022
  154. Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.